脂蛋白和静脉血栓栓塞:关联,因果关系和药物
Mariana B Pfeferman1, Sina Rashedi1, Gregory Y H Lip2,3
1Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Thrombosis and haemostasis
|August 22, 2025
概括
脂蛋白 (Lp) 是由基因决定的,与心血管疾病有关. 它与静脉血栓塞栓症 (VTE) 的关联不太清楚,尽管它具有潜在的前血栓性质,但需要进一步调查.
科学领域:
- 心血管医学
- 脂肪新陈代谢
- 血栓形成研究
背景情况:
- 脂蛋白 (a) [Lp (a) ]与LDL具有结构上的相似性,其基因决定的水平会影响心血管风险.
- 升高的Lp (a) 与动脉样硬化心血管疾病 (ASCVD) 和大动脉膜狭窄有关.
- 血栓塞栓症 (VTE) 与Lp(a) 之间的关联仍然不太清楚,对其血栓性有相互矛盾的证据.
研究的目的:
- 审查和批判性地分析目前关于Lp (a) 和VTE之间的相关证据.
- 探索将Lp (a) 与VTE联系在一起的病理生理机制.
- 评估Lp (a) 水平对静脉瘤结果的影响以及新兴疗法的潜在作用.
主要方法:
- 对实验,流行病学和遗传学研究进行全面审查.
- 对Lp (a) 的抗纤维解和前血栓性质的体外发现分析.
- 检查关于Lp (a) 水平和静脉突发症发生率和结果的临床数据.
主要成果:
- 虽然Lp(a) 具有体外前血栓性质,但临床和遗传研究显示与静脉瘤有不一致的关联.
- 一些证据表明VTE和非常高的Lp (a) 水平之间存在联系,但缺乏全面的结果数据.
- 新兴的Lp (a) 降低疗法显示显著降低,但它们对静脉瘤事件的影响目前尚不清楚.
结论:
- 需要进一步阐明Lp(a) 和静脉瘤之间的关系,特别是关于其血栓潜力和临床意义.
- 了解这种联系对于管理静脉瘤风险至关重要,尤其是在未来出现的针对性治疗中.
- 需要进一步的研究,以澄清Lp (a) 在静脉瘤发病中的作用,并评估Lp (a) 降低在静脉瘤预防中的临床效用.
相关概念视频
01:30Venous Thrombosis I: Introduction
40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34
01:30Atherosclerosis I: Introduction
77
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
77
01:30Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23